
23andMe Polygenic Risk Scores
When it comes to innovating genetic testing, 23andMe is always at the forefront of science. Not only were they one of the first companies on the genetic testing scene, but they were one of the first to get their breast-cancer screening test approved by the FDA. The company is partially owned by Google Ventures, Google’s start-up investment wing. This gives 23andMe a technological edge over other companies, and they are often the first on the market with a new offering. Recently, 23andMe started offering a polygenic risk score for diabetes, offering another thing to differentiate it in the 23andMe vs Ancestry battle and marking it as a top leader in both ancestry testing and health testing. [su_box title="Recent comment from the UK Health Minister" style="soft" title_color="#262424"]The UK Health Minister has…